American College of Mohs Surgery Meeting

Marty Makary, MD, MPH, predicts systemwide change in the world of health care.

At the current ACMS meeting, Kelsey E. Hirotsu, MD, discussed the bleeding complications seen in patients on ibrutinib for CLL.

A study presented at the current ACMS meeting highlights variables that could predict BCC, including: gender, immune status, and more.

Presenters highlight the possible solutions to communication between the scrubbed-in surgery team and outside help that could save time.

In a presentation at the current American College of Mohs Surgery meeting, Jennifer G. Powers, MD, highlights the needed improvement for immediate access to skin cancer care for VA patients, noting a 33 day average wait time compared to the VAs optimal goal of 28 days.

A poster at the 2022 American College of Mohs Surgery Annual Meeting examined the prevalence of bacterial organism colonization in Mohs wounds left to secondary intention.

Dermatology has enjoyed one of the lowest litigation rates among medical specialties, but recent findings presented at the 2022 American College of Mohs Surgery Annual Meeting caution that mounting risks relating to procedural dermatology and cutaneous oncology could change that.

Surgical site infections (SSIs) are a common adverse event after Mohs Micrographic Surgery, but researchers aimed to find out how the clinical features of gram-negative differ from their counterparts.

Starting today, the American College of Mohs Surgery is having their 54th Annual Meeting in Philadelphia, Pennsylvania.